Triple
T8809240
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Frederick National Laboratory for Cancer Research |
E209613
|
entity |
| Predicate | hasResearchProgram |
P3
|
FINISHED |
| Object |
AIDS and Cancer Virus Program
The AIDS and Cancer Virus Program is a research initiative focused on studying viruses that cause AIDS and cancer to advance prevention, diagnosis, and treatment strategies.
|
E759508
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: AIDS and Cancer Virus Program | Statement: [Frederick National Laboratory for Cancer Research, hasResearchProgram, AIDS and Cancer Virus Program]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: AIDS and Cancer Virus Program Context triple: [Frederick National Laboratory for Cancer Research, hasResearchProgram, AIDS and Cancer Virus Program]
-
A.
HIV Vaccine Trials Network
The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
-
B.
Center for Biostatistics in AIDS Research
The Center for Biostatistics in AIDS Research is a Harvard-based research center that develops and applies advanced statistical methods to improve the design, analysis, and interpretation of HIV/AIDS clinical and epidemiological studies.
-
C.
Centre for AIDS Programme of Research in South Africa
The Centre for AIDS Programme of Research in South Africa is a leading medical research institute focused on HIV/AIDS prevention, treatment, and epidemiology, based in South Africa.
-
D.
American Foundation for AIDS Research
The American Foundation for AIDS Research (amfAR) is a leading nonprofit organization dedicated to supporting HIV/AIDS research, prevention, treatment, and advocacy worldwide.
-
E.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: AIDS and Cancer Virus Program Triple: [Frederick National Laboratory for Cancer Research, hasResearchProgram, AIDS and Cancer Virus Program]
Generated description
The AIDS and Cancer Virus Program is a research initiative focused on studying viruses that cause AIDS and cancer to advance prevention, diagnosis, and treatment strategies.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: AIDS and Cancer Virus Program Target entity description: The AIDS and Cancer Virus Program is a research initiative focused on studying viruses that cause AIDS and cancer to advance prevention, diagnosis, and treatment strategies.
-
A.
HIV Vaccine Trials Network
The HIV Vaccine Trials Network is a global clinical trials organization dedicated to developing and testing preventive HIV vaccines through large-scale, collaborative research.
-
B.
Center for Biostatistics in AIDS Research
The Center for Biostatistics in AIDS Research is a Harvard-based research center that develops and applies advanced statistical methods to improve the design, analysis, and interpretation of HIV/AIDS clinical and epidemiological studies.
-
C.
Centre for AIDS Programme of Research in South Africa
The Centre for AIDS Programme of Research in South Africa is a leading medical research institute focused on HIV/AIDS prevention, treatment, and epidemiology, based in South Africa.
-
D.
American Foundation for AIDS Research
The American Foundation for AIDS Research (amfAR) is a leading nonprofit organization dedicated to supporting HIV/AIDS research, prevention, treatment, and advocacy worldwide.
-
E.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca8363f3308190a47e3f1ebd51f613 |
completed | March 30, 2026, 2:06 p.m. |
| NER | Named-entity recognition | batch_69cc5fd4cbec8190a929d4e60da8ad65 |
completed | March 31, 2026, 11:59 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69cf6fa0e4308190bd01c2d107c8c02d |
completed | April 3, 2026, 7:43 a.m. |
| NEDg | Description generation | batch_69cf718a6f2c81908f8b8d08a1437749 |
completed | April 3, 2026, 7:51 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69cf7275fea08190b8999fb30663ff17 |
completed | April 3, 2026, 7:55 a.m. |
Created at: March 30, 2026, 6:45 p.m.